Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 124.91%15.49B | ---- | ---- | ---- | 154.98%6.89B | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | 76.78%-49M | ---- | ---- | ---- | -955.00%-211M | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | -64.20%29M | ---- | ---- | ---- | -65.68%81M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -41.94%54M | ---- | ---- | ---- | -91.07%93M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -41.94%54M | ---- | ---- | ---- | -91.07%93M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -338.54%-1.68B | ---- | ---- | ---- | -227.57%-384M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -338.54%-1.68B | ---- | ---- | ---- | -227.57%-384M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -18.39%-103M | ---- | ---- | ---- | -1,187.50%-87M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---5M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -12.64%-98M | ---- | ---- | ---- | -1,187.50%-87M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | -0.86%7.14B | ---- | ---- | ---- | 9.55%7.2B | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | 1.88%4.06B | ---- | ---- | ---- | 24.19%3.99B | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | -29.73%104M | ---- | ---- | ---- | 5.71%148M | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 950.00%68M | ---- | ---- | ---- | 75.76%-8M | ---- | ---- |
| Special items | ---- | ---- | ---- | -34.20%2.35B | ---- | ---- | ---- | -42.87%3.57B | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 35.89%23.3B | ---- | ---- | ---- | 776.98%17.15B | ---- | ---- |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | ---- | ---- | 12.84%-224M | ---- | ---- | ---- | 86.13%-257M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 25.07%6.51B | ---- | ---- | ---- | 101.67%5.2B | ---- | ---- |
| Advance payment increase (decrease) | ---- | ---- | ---- | -15.92%660M | ---- | ---- | ---- | 332.25%785M | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | 164.14%490M | ---- | ---- | ---- | -37.16%-764M | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 174.53%79M | ---- | ---- | ---- | -10,500.00%-106M | ---- | ---- |
| Cash from business operations | ---- | -10.37%12.66B | ---- | 40.01%30.81B | ---- | 122.94%14.12B | ---- | 1,132.72%22B | ---- | 234.22%6.33B |
| Other taxs | ---- | -22.18%-876M | ---- | 16.52%-1.02B | ---- | 15.45%-717M | ---- | -23.54%-1.22B | ---- | -11.87%-848M |
| Special items of business | -8.02%19.45B | ---- | -43.36%3.28B | ---- | 78.07%21.15B | ---- | 1,537.29%5.8B | ---- | 529.20%11.88B | ---- |
| Net cash from operations | -8.02%19.45B | -12.11%11.78B | -43.36%3.28B | 43.34%29.79B | 78.07%21.15B | 144.33%13.4B | 1,537.29%5.8B | 2,513.96%20.78B | 529.20%11.88B | 200.16%5.49B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -22.51%530M | ---- | 198.07%772M | ---- | 505.31%684M | ---- | 167.01%259M | ---- | 769.23%113M |
| Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%53M | ---- | 218.60%51M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | --10M | ---- | --10M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | 149.11%1.85B | ---- | -389.42%-11.61B | ---- | -55.38%-3.77B | ---- | 68.55%-2.37B | ---- | 64.99%-2.43B |
| Sale of fixed assets | ---- | 122.22%20M | ---- | 70.00%17M | ---- | --9M | ---- | 25.00%10M | ---- | ---- |
| Purchase of fixed assets | ---- | -197.64%-7.08B | ---- | -64.65%-8.06B | ---- | 3.22%-2.38B | ---- | 3.98%-4.9B | ---- | -5.32%-2.46B |
| Recovery of cash from investments | ---- | 68.20%58.54B | ---- | 61.39%78.87B | ---- | 114.93%34.8B | ---- | 22.15%48.87B | ---- | -32.67%16.19B |
| Cash on investment | ---- | -43.44%-68.98B | ---- | -56.46%-96.67B | ---- | -166.14%-48.09B | ---- | -35.91%-61.78B | ---- | 31.05%-18.07B |
| Other items in the investment business | 17.06%-24.16B | ---- | -0.65%-4.94B | ---- | -98.70%-29.13B | ---- | -138.01%-4.9B | ---- | -12.74%-14.66B | ---- |
| Net cash from investment operations | 17.06%-24.16B | 19.32%-15.11B | -0.65%-4.94B | -84.63%-36.68B | -98.70%-29.13B | -183.98%-18.73B | -138.01%-4.9B | -10.19%-19.87B | -12.74%-14.66B | 42.36%-6.6B |
| Net cash before financing | 41.00%-4.71B | 37.45%-3.33B | -284.99%-1.65B | -852.18%-6.89B | -186.65%-7.99B | -379.91%-5.33B | 152.34%893M | 105.32%916M | 82.34%-2.79B | 93.44%-1.11B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -56.29%2.15B | ---- | --12.38B | ---- | --4.93B | ---- | ---- | ---- | ---- |
| Refund | ---- | -191.90%-1.26B | ---- | ---1.45B | ---- | ---432M | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | 1,540.00%164M | ---- | -86.76%29M | ---- | -85.71%10M | ---- | 305.56%219M | ---- | 150.00%70M |
| Interest paid - financing | ---- | -137.50%-24.58B | ---- | -156.51%-20.75B | ---- | -1,279.87%-10.35B | ---- | -587.43%-8.09B | ---- | ---750M |
| Issuance expenses and redemption of securities expenses | ---- | -8.84%-1.9B | ---- | -275.69%-4.88B | ---- | -1,363.87%-1.74B | ---- | ---1.3B | ---- | ---119M |
| Other items of the financing business | -34.84%4.95B | 130.87%30.1B | 119.96%560M | 118.72%24.63B | 1,025.63%7.6B | 274.84%13.04B | -383.33%-2.81B | 489.79%11.26B | 127.68%675M | --3.48B |
| Net cash from financing operations | -34.84%4.95B | -23.40%2.95B | 119.96%560M | 592.23%6.71B | 1,025.63%7.6B | 312.66%3.85B | -383.33%-2.81B | 47.52%-1.36B | 127.68%675M | 160.17%932M |
| Effect of rate | 66.67%-17M | -107.69%-1M | -163.64%-7M | -140.51%-32M | -146.79%-51M | -89.34%13M | 112.94%11M | -84.01%79M | -80.47%109M | -50.81%122M |
| Net Cash | 161.60%239M | 73.94%-386M | 42.89%-1.09B | 60.71%-176M | 81.62%-388M | -732.02%-1.48B | -167.04%-1.91B | 97.74%-448M | 88.41%-2.11B | 99.04%-178M |
| Begining period cash | -1.61%12.7B | -1.61%12.7B | -1.61%12.7B | -2.78%12.91B | -2.78%12.91B | -2.78%12.91B | -2.78%12.91B | -59.30%13.27B | -59.30%13.27B | -59.30%13.27B |
| Cash at the end | 3.63%12.92B | 7.63%12.31B | 5.40%11.6B | -1.61%12.7B | 10.59%12.47B | -13.47%11.44B | -11.78%11B | -2.78%12.91B | -24.65%11.27B | -8.15%13.22B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unaudited opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.